TY - JOUR T1 - Keratopigmentation with micronised mineral pigments: complications and outcomes in a series of 234 eyes JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 742 LP - 747 DO - 10.1136/bjophthalmol-2017-310591 VL - 102 IS - 6 AU - Jorge L Alio AU - Olena Al-Shymali AU - Maria A Amesty AU - Alejandra E Rodriguez Y1 - 2018/06/01 UR - http://bjo.bmj.com/content/102/6/742.abstract N2 - Aim To report the complications observed in a consecutive large series of cases treated with keratopigmentation (KTP).Methods KTP was performed in 234 eyes of 204 patients for therapeutic and cosmetic reasons. From them, 50 eyes of 29 patients suffered complications. Different KTP techniques and three generations of pigments (GP) were used. The follow-up period ranged from 4 months to 12 years. Light sensitivity (LS), visual field (VF) limitations and MRI alterations were considered functional complications. Organic complications were described as change in colour, colour fading and neovascularisation.Results The percentage of complications was 12.82%. Most patients complained of LS (49%), then colour fading and change in colour (19%). Neovascularisation, VF limitations and MRI complications constituted 7%, 4% and 2%, respectively. Organic complications were observed with the previous GP but resolved with the latest third GP with CE mark certification (Conformité Européene). Although LS remained with the corneal-specific pigments, it gradually disappeared in most of the patients (81.81%) 6 months postoperatively.Conclusion To the best of our knowledge this is the first time a study systematically and comprehensively approaches and reports KTP complications. KTP with third GP provides better results and fewer complications than previous ones. It is a modern, minimally invasive technique that helps solve several functional ocular problems and improves cosmetic appearance of the patients. Dermatological pigments should not be used as they lead to complications; instead pigments specifically tested for the eye in terms of toxicity and teratogenicity should be used. ER -